Amarant Pharmaceuticals products and prices in Pakistan
Manufacturer Holds a DRAP Drug Manufacturing Licence (DML) for its products. Source: DRAP.
Follow price changes 🔒 Company report (Pharma Pro)Private pharmaceutical manufacturer · Karachi · Pakistan
Karachi-based pharmaceutical manufacturer with pharmaceutical and nutraceutical portfolios, quality, regulatory and export functions.
Amarant Pharmaceuticals products in Pakistan
Amarant Pharmaceuticals Private Limited has 143 medicine presentations registered in Pakistan under 68 brands, covering 59 generic medicines. Most of its products are in Anti-infectives, CNS & mental health and Cardiovascular. Its brands with the most registered strengths and packs are Listan AH (Amlodipine + Valsartan + Hydrochlorothiazide), Amprexa-F (Olanzapine + Fluoxetine), Neoris (Risperidone) and Azirant (Azithromycin). 143 products have an official DRAP price on MedInfoBase. See all 68 brands A to Z
What is sourced, and how recent is it?
Regulatory-source portfolio data and company-supplied/corporate profile fields are tracked separately. Company claim/verification status is separate from source quality. An unclaimed company can still have a fully official-source-observed portfolio.
Company profile
- Legal / official name
- Amarant Pharmaceuticals (Private) Limited
- Company type
- Private pharmaceutical manufacturer
- Address
- Plot #168, Sector 23, Korangi Industrial Area, Karachi, Pakistan
- Website
- amarantpharma.com ↗
- Phone
- +92 21 35121361-63
- Official contact
- Contact page ↗
- Corporate source details checked
- 16 Aug 2026
- Corporate profile completeness
- 88%
Company location
A sourced company location is recorded. Use the map link below for directions.
Portfolio at a glance
RegistrationA unique regulatory registration number. One registration may have more than one strength/form/pack presentation.
PresentationA distinct medicine presentation, such as a particular strength, dosage form and pack.
IndexedA canonical MedInfoBase presentation that passed MedInfoBase identity and publication controls.
Source observedAn additional presentation observed in an official DRAP source but not counted as an indexed MedInfoBase presentation.
Registry onlyAn exact registry-verified registration not otherwise represented by an indexed or source-observed presentation.
Registry verifiedAn exact registration match found in an official DRAP registry source. This is evidence status, not a commercial ranking.
How complete is this profile?
Downloadable company intelligence charts
Copy or download any chart as a presentation-ready PNG. Every exported chart keeps MedInfoBase attribution and the source company-profile URL.
Therapeutic Portfolio Mix
Shows where the company portfolio is concentrated across broad therapeutic areas.
Portfolio distribution, not sales or market-share data.
Dosage Form Portfolio
Shows how the company portfolio is distributed across tablets, capsules, injections, liquids and other forms.
Counts are product presentations, not production or sales volumes.
Equivalent Price Position
Shows whether safely comparable products are below, near or above the peer median unit price.
This is price-position intelligence, not sales, demand or market-share data.
Closest Portfolio Competitors
Highlights other manufacturers with the greatest generic overlap with this company portfolio.
Competitor ranking is based on shared generics in MedInfoBase, not commercial sales performance.
Therapeutic areas
High-level clinical areas represented by this company’s current MedInfoBase portfolio.
Drug classes
More specific classes derived from the canonical generic and preserved curated classifications.
Dosage forms
How MedInfoBase classifies the portfolio
MedInfoBase uses a two-level taxonomy. Therapeutic area is a broad portfolio category, while drug class is the more specific pharmacological or clinical class. Existing curated classifications are preserved. Blank records are assigned conservatively from the canonical generic name and, when available, ATC information. Multi-use medicines may be placed in a cross-therapeutic category rather than forced into a single indication.
Deepest brand families
Unit-price positioning vs equivalent products
See where Amarant Pharmaceuticals Private Limited is priced against the market
127 of its products have like-for-like competitors. Pharma Pro shows how many are priced below, near or above the market median, the company's overall price position, and product-by-product examples.
How MedInfoBase calculates price position
Only current prices with safely interpretable pack quantities are used. A product is compared only with the same generic, same stated strength, same dosage form and a compatible unit basis such as tablet, capsule, mL or gram. These are database-derived price comparisons, not sales or market-share estimates.
Portfolio overlap
Companies sharing the largest number of generics with this portfolio. This measures product overlap, not commercial performance.
🔒 3 more overlapping companies, with shared-generic detail, in Pharma Pro. Unlock
Observed database signals
These dates describe records observed by MedInfoBase. They should not be interpreted as product launch dates or sales activity.
Medicine portfolio
This unified portfolio keeps three evidence lanes distinct: indexed MedInfoBase presentations, additional source-observed presentations, and registry-only registrations that are not otherwise represented. A registration number is not the same thing as a presentation, and source-observed rows are not counted as indexed. Source-only rows with a strength/form/pack contradiction remain visible as evidence but the conflicting field is held for normalization.
| Brand | Generic | Strength | Form | Pack | Registration | Source-listed price | Unit price | Price position |
|---|---|---|---|---|---|---|---|---|
| Floxicon | Ofloxacin | 200 mg | Tablet | 10’s | 042071 | PKR 237.52 | PKR 23.75/tablet | 🔒 Pharma Pro |
| Floxicon | Ofloxacin | 400 mg | Tablet | 10’s | 042072 | PKR 309.80 | PKR 30.98/tablet | 🔒 Pharma Pro |
| Moxina | Moxifloxacin | 400 mg | Tablet | 5’s | 057783 | PKR 712.54 | PKR 142.51/tablet | 🔒 Pharma Pro |
| Neoage | Ciprofloxacin | 250 mg | Tablet | 10's | 042067 | PKR 268.49 | PKR 26.85/tablet | 🔒 Pharma Pro |
| Neoage | Ciprofloxacin | 500 mg | Tablet | 10's | 042068 | PKR 371.74 | PKR 37.17/tablet | 🔒 Pharma Pro |
| Quvoxin | Levofloxacin | 250 mg | Tablet | 10’s | 042069 | PKR 516.32 | PKR 51.63/tablet | 🔒 Pharma Pro |
| Quvoxin | Levofloxacin | 500 mg | Tablet | 10’s | 042070 | PKR 859.17 | PKR 85.92/tablet | 🔒 Pharma Pro |
| Quvoxin | Levofloxacin | 500 mg/100 mL | IV infusion | 1's | 083041 | PKR 509.05 | PKR 509.05/vial/unit | 🔒 Pharma Pro |
All 68 Amarant Pharmaceuticals brands in Pakistan
- Acetra Tramadol + Paracetamol · 325 mg + 37.5 mg tablet
- Alzolid Linezolid · 600 mg tablet
- Amaquel ER Quetiapine · 400 mg tablet
- Amaquel SR Quetiapine · 150 mg tablet, 200 mg tablet, 300 mg tablet
- Amblum Artemether + Lumefantrine, Artemether · 20 mg + 120 mg tablet, 240 mg + 240 mg tablet, 80 mg/mL injection
- Amblum Forte Artemether + Lumefantrine · 80 mg + 480 mg tablet
- Amiceft Ceftazidime · 1 g injection, 250 mg injection, 500 mg injection
- Amlepo Clozapine · 100 mg tablet, 25 mg tablet
- Amlosyl Amlodipine · 10 mg tablet
- Ampol Paracetamol · 500 mg tablet
- Amprexa-F Olanzapine + Fluoxetine · 12 mg + 25 mg capsule, 6 mg + 25 mg capsule
- Amtraxa Ceftriaxone · 1 g injection, 250 mg injection, 500 mg injection
- Aprant Aprepitant · 125 mg capsule, 40 mg capsule, 80 mg capsule
- Azirant Azithromycin · 200 mg/5 mL suspension, 250 mg capsule, 250 mg tablet
- Cefirant Cefixime · 200 mg capsule, 400 mg capsule
- Cefirant Dry Cefixime · 100 mg/5 mL suspension
- Cefirant DS Cefixime · 200 mg/5 mL suspension
- Chlorilex Chlorpheniramine · 2 mg/5 mL syrup, 4 mg tablet
- Clopilet Clopidogrel · 75 mg tablet
- Clotricon Clotrimazole · 500 mg pessary
- Clotricon Vaginal Clotrimazole · 2% cream
- Cyclorant Cycloserine · 250 mg capsule
- Deprion SR Bupropion · 150 mg tablet, 300 mg tablet
- Dipodium Divalproex sodium, Sodium valproate · 250 mg tablet, 250 mg/5 mL syrup, 500 mg/5 mL syrup
- Dipodium DS Divalproex sodium · 500 mg tablet
- Edper Permethrin · 5% cream
- Edtac Ointment Tacrolimus · 1 mg ointment
- Feriant Iron protein succinylate · 800 mg/15 mL (equiv. 40 mg elemental iron) syrup, 800 mg/5 mL syrup
- Floxicon Ofloxacin · 200 mg tablet, 400 mg tablet
- Fludine Loratadine · 10 mg tablet
- Getex Cefotaxime · 1 g injection, 250 mg injection, 500 mg injection
- Habrin Ribavirin · 200 mg capsule, 400 mg capsule
- Hemosoft Iron polymaltose complex · 100 mg tablet, 50 mg/5 mL syrup
- Hemosoft-F Iron polymaltose complex · 100 mg tablet
- Hysim-E Ezetimibe + Simvastatin · 10 mg + 10 mg tablet, 20 mg + 20 mg tablet
- Ibulexin Ibuprofen · 200 mg tablet
- Lexazole Metronidazole · 200 mg tablet, 200 mg/5 mL suspension
- Lexazole DS Metronidazole + Diloxanide furoate · 400 mg + 500 mg tablet
- Lexidox Doxycycline · 100 mg tablet
- Lexitran Sulfamethoxazole + Trimethoprim · 80 mg + 400 mg tablet
- Lignorant Lidocaine · 2% w/w gel
- Limgit Lamotrigine = · 100 mg tablet, 25 mg tablet, 50 mg tablet
- Listan AH Amlodipine + Valsartan + Hydrochlorothiazide · 10 mg + 160 mg + 12.5 mg tablet, 10 mg + 160 mg + 25 mg tablet, 10 mg + 320 mg + 25 mg tablet
- Listan AM Amlodipine + Valsartan · 10 mg + 160 mg tablet, 5 mg + 80 mg tablet
- Listan HT Valsartan + Hydrochlorothiazide · 160 mg + 12.5 mg tablet, 80 mg + 12.5 mg tablet
- Lozatin Losartan · 50 mg tablet
- Luna Clarithromycin · 250 mg tablet, 500 mg tablet
- Mefirant Mefenamic acid · 250 mg tablet
- Moxina Moxifloxacin · 400 mg tablet
- Neoage Ciprofloxacin · 250 mg tablet, 500 mg tablet
- Neoris Risperidone · 1 mg tablet, 1 mg/mL solution, 2 mg tablet
- Nojer Metformin · 500 mg tablet
- Orpara Paracetamol · 450 mg tablet
- Oselvir Oseltamivir · 75 mg capsule
- Oselvir dry Oseltamivir · 12 mg/mL suspension
- Ozker Omeprazole · 20 mg capsule
- Perm Permethrin · 5% lotion
- Pio-M Metformin · 500 mg tablet, 800 mg tablet
- Quichin Chloroquine · 250 mg tablet, 50 mg/5 mL syrup
- Quichin-H Hydroxychloroquine · 200 mg tablet
- Quvoxin Levofloxacin · 250 mg tablet, 500 mg tablet, 500 mg/100 mL infusion
- Rilorant Lopinavir + Ritonavir · 200 mg + 50 mg tablet
- Rozicon-M Metformin + Rosiglitazone · 500 mg + 2 mg tablet, 500 mg + 4 mg tablet
- Thicar SR Lithium carbonate · 400 mg tablet
- Vetrawin Levetiracetam · 100 mg/mL solution, 250 mg tablet, 500 mg tablet
- Zisu Zinc · 10 mg suspension
- Zisu Dry Zinc, Zinc sulfate · 10 mg/5 mL suspension
- Zisu-OD Zinc sulfate, Zinc (elemental) · 10 mg tablet, 20 mg elemental zinc tablet
Amarant Pharmaceuticals: common questions
How many products does Amarant Pharmaceuticals have in Pakistan?
Amarant Pharmaceuticals Private Limited has 143 registered medicine presentations in Pakistan, sold under 68 brands and covering 59 generic medicines.
What are the main brands of Amarant Pharmaceuticals?
By number of registered strengths and packs, its largest brands are Listan AH (Amlodipine + Valsartan + Hydrochlorothiazide), Amprexa-F (Olanzapine + Fluoxetine), Neoris (Risperidone), Azirant (Azithromycin) and Vetrawin (Levetiracetam). This is not a sales ranking.
Which therapy areas does Amarant Pharmaceuticals cover?
The most products are in Anti-infectives (55), CNS & mental health (39), Cardiovascular (18), Vitamins, minerals & nutrition (10) and Pain & musculoskeletal (5).
Where can I see Amarant Pharmaceuticals medicine prices?
Open any brand in the list above for its official DRAP price, pack sizes, price history and other brands of the same medicine.
MedInfoBase company-intelligence methodology
This page is generated from MedInfoBase medicine, generic, company, price and official-source records. Unverified third-party discovery records are retained internally for coverage auditing and are not published as company registrations. Portfolio leaders are ranked by presentation depth, not sales. Price-position metrics are calculated from current official-source prices normalized to compatible units and compared only against like-for-like products with the same generic, stated strength and dosage form.
Not currently included: sales volume, revenue by brand, market share, prescription volume or best-selling rankings. MedInfoBase will display those only when supported by a defensible licensed, public or company-verified source.
Cite this record
Manufacturer recordRecords change over time. Please cite the access date so readers can locate the version you used.